Post by
bligicka on Jan 25, 2021 7:39pm
Oral 💊 is the game changer !!!
Without oral Vaxil is just another potential vaccine that doesn't even have phase 1 timelines ......nobody will care ... with oral they have an opportunity to make a real difference in the world
Comment by
Jlane17 on Jan 25, 2021 8:01pm
I'm sorry Padina but they are not the only company to submit a challenge. I don't think you have a understanding of the difference between an oral application and a vaccine that requires shots in your arm. A positive result would be great in the mice experiment, what would even be better is they can generate a immune response with the oral application.
Comment by
bligicka on Jan 25, 2021 8:20pm
Thats the news I'm looking for .... a immune response with the oral application ... that is the true game changer !!!!.... lots of vaccines out there now but no other oral applications as of yet anyways .....
Comment by
Jlane17 on Jan 25, 2021 9:06pm
Do some research before posting check out vaxart oral pill already in clinical testing with results soon to be announced. Do some homework
Comment by
bligicka on Jan 25, 2021 9:09pm
Vaxil and Vaxart either way Oral would be the huge advantage to getting funding and investor attention as a oral form could be sent to Africa or South America for mass distrubution without the need of syringes or fancy -80 fridges
Comment by
bligicka on Jan 25, 2021 9:15pm
So where is the Oral exploratory preclinical study taking place if its not in Maryland ???
Comment by
Padina on Jan 25, 2021 9:27pm
Its anywhere but USAMRIID How do you even give tablet to mice unless of course u ground the tablet and that would have defeated the aim of the study bcos the dissolution rate will be unknown if tablet is grounded/disentegrated b4 giving the mouse? i would think tablet study should require a primate. With mice, the best form is either nasal or injection
Comment by
Red~One on Jan 25, 2021 9:31pm
"We anticipate the first Corvaxâ„¢ injections in mice will be administered during the week of December 14, 2020." News release Dec 3, 2020